Author

R. Leibel

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:metabolism & bioenergetics· 1 Organism:mouse· 1

Frequent Co-Authors

B. Diaz· 1 shared D. Accili· 1 shared N. Sultana· 1 shared S. Belvedere· 1 shared T. Kitamoto· 1 shared W. Du· 1 shared Y. NieiD· 1 shared Y.-K. Lee· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

B. Diaz

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Single-agent Foxo1 inhibition normalizes glycemia and induces gut β-like cells in streptozotocin-diabetic mice

Y.-K. Lee, Y. Nie, B. Diaz, N. Sultana, T. Kitamoto, W. Du, R. Leibel, D. Accili, S. Belvedere

This study shows that Foxo1 inhibitors reduce blood glucose and generate gut β-like cells in diabetic mice, suggesting they could be an alternative to insulin.

bioRxiv · Mar 26, 2022Pharmacology & Toxicology